This site uses cookies. By using this site you agree to receiving cookies. View Policy.
:quality(60)/https://files-crowdcube-com.s3.amazonaws.com/opportunity_images/24583/201903/5200b42dd17cddf94841d6c67192e48e.jpg "Belluscura plc")
/https://files-crowdcube-com.s3.amazonaws.com/files/pitch_pics/original/201808/c75467a42f1d420783ee73ab9616c0a6 "Belluscura plc")
Belluscura has developed the X-PLOR, a lightweight, portable oxygen delivery device aimed at treating the millions of people globally suffering from chronic lung diseases. The company plans to launch this novel and cost-effective device in the US in 2019, with Europe to follow.
News
| Tekcapital investee Belluscura eyes raising GBP17.5 million in AIM IPO Morning Star |
21/05/2021 |
| Intention to float - AIM London Stock Exchange |
07/05/2021 |
| Medical device firm Belluscura has revealed plans for a London float CityAM |
16/11/2017 |
| Belluscur plans London float CityAM |
16/11/2017 |
| Acquisition for medical device company Insider Media |
27/04/2017 |
